01171nas a2200193   4500000000100000008004100001260001300042653003800055653003900093653002200132100001500154700001300169700001500182245010000197856007900297300001200376490000600388520058300394       2017                            d  bElsevier10aSoil-Transmitted Helminths (STHs)10aNeglected tropical diseases (NTDs)10aMorbidity control1 aAndrews JR1 aBogoch I1 aUtzinger J00aThe benefits of mass deworming on health outcomes: new evidence synthesis, the debate persists.  uhttp://www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X(16)30333-3.pdf  ae4–e50 v53 a<p>Soil-transmitted helminthiasis and schistosomiasis affect more than 1 billion people, with the greatest burden in the poorest regions of the world. The global strategy for addressing these parasitic worm infections is mass deworming with anthelminthic drugs that are periodically administered to school-aged children and other high-risk groups. Traditionally, mass deworming is provided to all school-aged children, rather than a screen-and-treat approach. The goal is to control morbidity at the population level, which might reduce disease transmission.<br />
&nbsp;</p>